Key Insights

Highlights

Success Rate

78% trial completion

Published Results

34 trials with published results (13%)

Research Maturity

109 completed trials (43% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

12.3%

31 terminated out of 253 trials

Success Rate

77.9%

-8.7% vs benchmark

Late-Stage Pipeline

9%

22 trials in Phase 3/4

Results Transparency

31%

34 of 109 completed with results

Key Signals

34 with results78% success31 terminated

Data Visualizations

Phase Distribution

153Total
Not Applicable (97)
Early P 1 (1)
P 1 (22)
P 2 (11)
P 3 (14)
P 4 (8)

Trial Status

Completed109
Unknown34
Recruiting32
Terminated31
Withdrawn19
Active Not Recruiting12

Trial Success Rate

77.9%

Benchmark: 86.5%

Based on 109 completed trials

Clinical Trials (253)

Showing 20 of 20 trials
NCT07386548Not ApplicableRecruitingPrimary

Biologic Injection For Adults With Lumbar Disc Herniation

NCT05508360Not ApplicableRecruitingPrimary

"Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nulcectomy" (LOPAIN2)

NCT07254806Phase 3RecruitingPrimary

A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease

NCT06438471Phase 1Recruiting

Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury

NCT05037968Not ApplicableRecruitingPrimary

MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion

NCT06115512Phase 3TerminatedPrimary

A Phase 3 Study of AGA111 in Patients With Degenerative Disc Disease Undergoing Lumbar Interbody Fusion

NCT06226272RecruitingPrimary

Clinical Outcome Measure at Stryker Spine

NCT06325566Phase 3Active Not RecruitingPrimary

Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain

NCT06615505Phase 2Active Not RecruitingPrimary

ASCEND: A Clinical Trial to Evaluate the Safety and Effectiveness of VIA Disc NP, a Supplement for Degenerated Intervertebral Discs

NCT05329129RecruitingPrimary

OssDsign® Spine Registry Study ("Propel")

NCT04982965Early Phase 1Recruiting

Brain Mechanisms Supporting Cannabis-induced Pain Relief

NCT06144970Phase 1Not Yet RecruitingPrimary

Study to Determine the Safety and Tolerability of TG-C in Subjects With Back Pain Due to Degenerative Disc Disease

NCT06462729Phase 1RecruitingPrimary

LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)

NCT06209684Not ApplicableRecruitingPrimary

Carbofix Pedicle Screw System: Evaluation of the Clinical and Radiographic Outcomes of the Use of a Carbon Fiber Device Compared to Titanium Devices in Patients Undergoing Spinal Arthrodesis for Degenerative Spinal Diseases

NCT07580664Not ApplicableNot Yet RecruitingPrimary

Long-term Assessment of BDyn Dynamic Stabilization Device in Patients With Lumbar Degenerative Disc Disease

NCT07017634Phase 3RecruitingPrimary

Efficacy and Safety of Novosis Putty in Transforaminal Lumbar Interbody Fusion for Patients With Lumbar Degenerative Disc Disease

NCT06778447Not ApplicableRecruitingPrimary

Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease

NCT03398915Active Not RecruitingPrimary

The European Robotic Spinal Instrumentation (EUROSPIN) Study

NCT05296889Recruiting

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical

NCT04214535Not ApplicableActive Not Recruiting

Anterior Cervical Disectomy And Fusion Using The Tritanium® C Anterior Cervical Cage For One Or Two-Levels

Scroll to load more

Research Network

Activity Timeline